Shan Q. Xu

#277 Yanta West Road
Xi'an, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Loss of CYLD on Chromosome 16q Impairs Homologous Recombination and Genomic Stability Through TIRR Degradation.

Loss of CYLD on Chromosome 16q Impairs Homologous Recombination and Genomic Stability Through TIRR Degradation.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: May 13, 2026

Correction: RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial-mesenchymal transition via MAPK/SOX2 pathway in bladder cancer.

Correction: RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial-mesenchymal transition via MAPK/SOX2 pathway in bladder cancer.

Journal: Cell death & disease

Published: April 17, 2026

USP10 regulates HIF2α stability by deubiquitinating HIF2α regardless of VHL status in kidney cancer.

USP10 regulates HIF2α stability by deubiquitinating HIF2α regardless of VHL status in kidney cancer.

Journal: Translational andrology and urology

Published: October 15, 2025

Multi-stimuli activated PROTAC prodrug for controlled protein degradation with enhanced therapeutic effects.

Multi-stimuli activated PROTAC prodrug for controlled protein degradation with enhanced therapeutic effects.

Journal: European journal of medicinal chemistry

Published: August 22, 2025

Application and progress of magnetic surgical technique in organ anastomosis reconstruction

Application and progress of magnetic surgical technique in organ anastomosis reconstruction

Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]

Published: August 20, 2025

RAD51-targeting small molecule degrader sensitizes BRCA-proficient prostate cancer cells to PARP inhibitors via synthetic lethality.

RAD51-targeting small molecule degrader sensitizes BRCA-proficient prostate cancer cells to PARP inhibitors via synthetic lethality.

Journal: Acta pharmaceutica Sinica. B

Published: August 04, 2025

The Establishment of Prostate-specific, SKP2 Humanized Mice by CRISPR Knock-in Method Reveals Neoplastic Initiation and Microenvironmental Reprogramming.

The Establishment of Prostate-specific, SKP2 Humanized Mice by CRISPR Knock-in Method Reveals Neoplastic Initiation and Microenvironmental Reprogramming.

Journal: bioRxiv : the preprint server for biology

Published: July 14, 2025

Ubiquitination-directed cytosolic DNA degradation governs cGAS-STING-mediated immune response to DNA damage.

Ubiquitination-directed cytosolic DNA degradation governs cGAS-STING-mediated immune response to DNA damage.

Journal: Cancer cell

Published: April 25, 2025

BAY11-7082 Targets RNF25 to Reverse TRIP4 Ubiquitination-dependent NF-κB Activation and Apoptosis Resistance in Renal Cell Carcinoma.

BAY11-7082 Targets RNF25 to Reverse TRIP4 Ubiquitination-dependent NF-κB Activation and Apoptosis Resistance in Renal Cell Carcinoma.

Journal: International journal of biological sciences

Published: April 03, 2025

The RNA binding protein CARHSP1 facilitates tumor growth, metastasis and immune escape by enhancing IL-17RA mRNA stabilization in prostate cancer.

The RNA binding protein CARHSP1 facilitates tumor growth, metastasis and immune escape by enhancing IL-17RA mRNA stabilization in prostate cancer.

Journal: Cell & bioscience

Published: January 02, 2025

Cancer-associated SPOP mutations enlarge nuclear size and facilitate nuclear envelope rupture upon farnesyltransferase inhibitor treatment.

Cancer-associated SPOP mutations enlarge nuclear size and facilitate nuclear envelope rupture upon farnesyltransferase inhibitor treatment.

Journal: The Journal of clinical investigation

Published: November 11, 2024

A Peptide-Based PROTAC Degrader of BRCA2 Sensitizes Metastatic Castration-Resistant Prostate Cancer to PARP Inhibition.

A Peptide-Based PROTAC Degrader of BRCA2 Sensitizes Metastatic Castration-Resistant Prostate Cancer to PARP Inhibition.

Journal: Cancer research

Published: November 01, 2024

Showing 1-12 of 54

Last Updated: 09/26/2026